Change to the information provided on adverse events in the Summary of Product Characteristics for Meflosyl 5% Solution for Injection, authorised for use in horses.
Any veterinary medicinal product which is authorised for marketing in the UK will have its Summary of Product Characteristics (SPC) available on our Product Information Database which can be accessed at https://www.vmd.defra.gov.uk/productinformationdatabase/ .
No medicine is 100% risk free, the SPC includes information on what adverse events have been known to occur following administration of a particular product, these can be found in either section Adverse events (3.6) or Adverse reactions (4.6).
Following monitoring of pharmacovigilance data, the Summary of Product Characteristics (SPC) for Meflosyl 5% Solution for Injection has been updated:
Section 4.6 now states that in very rare cases allergic reactions (anaphylaxis) may occur after administration of the veterinary medicinal product.
All updates to SPCs other than template changes, are published in the medicine updates section of VMD Connect which can be accessed at: https://www.vmdconnect.uk/medicines-update
